BioSpace News Archive

PolyPid Ltd. announced today that the 750th patient has been enrolled into its ongoing pivotal Phase 3 SHIELD I study evaluating D-PLEX 100 for the prevention of surgical site infections (SSIs) in abdominal surgery.

Plasma, often referred to as the fourth state of matter, is an ionized or energized gas with an equal number of positive and negative charges.

Lansoprazole is a proton pump inhibitor drug, which prevents the stomach from producing gastric acid to facilitate treatment of various gastric disorders.

Home care medical devices are intentional for use in any location outside a professional health care facility.

The present research report offers comprehensive analysis of the global drug eluting balloon market for the forecast period of 2019 to 2029.

DUBAI, United Arab Emirates, Expanding at a CAGR of 4.9%, the global Compression Garments and Stockings Market is expected to increase from a valuation of US$ 2.8 Bn in 2022 to US$ 3.9 Bn by 2029.

A combination vaccine is a mixture of two or more than two vaccines that could be administered separately, which is put into a single shot.

Mainz Biomed N.V. announced that, together with its German partner laboratories, it will join a collective of physicians, healthcare professionals, laboratories and healthcare organizations in a national campaign to raise awareness for Colorectal Cancer screening.

Anteris Technologies Ltd (Anteris or the Company) Limited (ASX: AVR) announces the Company has entered a binding agreement to place 1,840,000 new Ordinary Shares ( New Shares ) raising USD 20 million ($A 28 million) to Perceptive Life Sciences Master Fund, Ltd and managed by Perceptive Advisors ( Perceptive ) at $A15 a share, representing a 20% discount to the closing price on 28 February 2022.

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted 17 newly-hired employees stock options to purchase an aggregate of 228,000 shares, and restricted stock units covering an aggregate of 62,000 shares, of BioCryst common stock.